Your statement ...'you have to realise that'.
No, I do very nicely thank you, either picking winners, or trading, but trying to be ethical in my approach.
Sure I have my losers, each of us do but I hope GDR will succeed
IMO |
The product works and no....there are NOT plenty of companies 'where that is the case.'
GDT Has it's patents.
So I believe we just need 'patience' and the abilty, to ignore posters like you who change sides depending on their current trade. |
Hazl once again and as up keep saying things change and you have to realise that or lose ,something you are totally incapable of doing it seems
They have spent too much and not generated enough revenues in time before the next raise has become due and therefore it's a sell until that has been resolved .
The product works but there are plenty of companies where that is the case ,however turning them into profit makers is a different story and so far gdr are some way off that . Then next fund raise likely 1p possibly less might be worth a punt again then for the FDA news when that is nearer . Until the funding is sorted it's a sell and watch the graph as funding gets closer |
 bones698 - 29 Nov 2024 - 10:43:38 - 10137 of 10252 Genedrive, A Game Changer for Point of Care Testing Market? - GDR
'Likewise, full recommendation of our CYP2C19 ID kit and the need for interventional CYP2C19 genotyping in ischaemic stroke and transient ischaemic attack by NICE and positive value assessment by the Scottish Health Technology Group, with health economics estimated to be in the order of £160m financial savings to NHS England per year are powerful drivers of anticipated uptake. Performance of our CYP2C19 ID kit in clinical studies under the DEVOTE program was exceptional, with our device outperforming the laboratory platform costing approximately 20X more with respect to speed of time to result, accuracy and target coverage. Whilst positioned primarily for near-patient testing, our CYP2C19 test with its clear advantages is equally at home in traditional laboratory settings
Says it all im surprised the trolls have turned up now their arguments have been blown apart and shown to be total lies'
bones698 - 29 Nov 2024 - 08:50:44 - 10128 of 10252 Genedrive, A Game Changer for Point of Care Testing Market? - GDR
'Will get bought next year imo' |
It's dropping again |
not a bad volume for a monday morn! |
The pounds have plummeted and investors are leaving the UK stocks market. Tough times and these guys are burning 700K in money |
Crypto doesn't require 700K every month to run the company with nothing to show for and it can do several thousands X. This 💩💩 is going backwards |
Genedrive has brilliant products and lots of interest in the right places.
The share price doesn't do it justice but the market might well catch up eventually.
We'll see.
IMO |
Thanks Indian.Hazl, when you look at the threads that this bozo posts on they are all Purple11/Z1co related, and all pushing a negative agenda. It doesn't take a genius to deduce that this is just another disgruntled idiot or side avatar of a regular poster that is here to post one liners to Garner a response.Very much best ignored. |
This is more riskier than crypto, the company is at the mercy of funding,
cannot see it surviving long |
Yes when it's ten times the price!
People have to do their own thing.
If people choose to take the risk, when it is at this lowly price, who are you to tell them what to do?
And why are you so often here, to direct them?
Because you stand to benefit one way or another if they quit.
Please don't tell me you do it out of the goodness of your heart beause I don't think you can have one.
imo |
All the money are going into Crypto
The market doesn't wait these days
Come back when they have a fully licensed and tested product with sales lined up |
Interesting Indomie.
We are of course very news dependent.
But definitely on more radars than we were in my opinion.
Such a worthwhile company.
We just want a share price to match. |
No, the 'promoters' are successfully trading the peaks here whilst having a core holding at just above the current share price for when it finally breaks out.But thanks for playing. |
Looks like pharma stock APH the first on AIM to go private in 2025, bid at a 41% premium, tho well down on highs from a couple of years ago. |
Has the promoters finished jumped ship |
Here comes the walk down to the next placing in a month or two imo it's coming no point denying it the figures are there for all to see |
Anyone seen the the news, 91 hours wait at A&E. What does this mean?
It means the NHS are extremely understaffed from lack of funding.
Not a penny to spare to fund GDR kits. |
pdfile machine siko is dead. The bearded child from Rochdale got hit. amen |
You must be worried it's going to rise....to post so much?
Surely if it was definitely going to fail you could sit back and wait for the inevitable?
Yep.
You are worried and the anxiety is definitely in proportion to the number of your posts.
IMO |
The NHS will not fund this. Britain is poor. PIs will fund this until the research dries up and then they will be left starring down the black hole the funds went into. |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
